Vaccination with a recombinant vaccinia vaccine containing the B7-1 co- stimulatory molecule causes no significant toxicity and enhances T cell- mediated cytotoxicity

International Journal of Cancer

Volumn 85, Issue 4, 2000, Pages 508-517

  Freund, Yvonne R ^a   Mirsalis, Jon C ^a   Fairchild, David G ^a   Brune, Joyce ^a   Hokama, Leslie A ^a   Schindler Horvat, Janice ^a   Tomaszewski, Joseph E ^b   Hodge, James W ^b   Schlom, Jeffrey ^b   Kantor, Judy A ^b   Tyson, Charles A ^a   Donohue, Susan J ^b  

^a SRI INTERNATIONAL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN LYMPHOCYTE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VACCINIA VIRUS;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGENS, CD80; BLOOD CELL COUNT; BLOOD UREA NITROGEN; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; IMMUNITY, CELLULAR; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES; VACCINES, SYNTHETIC; VACCINIA VIRUS;

EID: 0033956001     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000215)85:4<508::AID-IJC11>3.0.CO;2-D     Document Type: Article

References (22)

1. AKAGI, J., HODGE, J.W., MCLAUGHLIN, J.P., GRITZ, L., MAZZARA, G., KUFE, D., SCHLOM, J. and KANTOR, J.A., Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUCI gene and the murine T-cell co-stimulatory molecule B7. J. Immunother., 20, 38-47 (1997).
2. AZUMA, M., CAYABYAB, M., PHILLIPS, J.H. and LANIER, L., Requirements for CD28-dependent T cell-mediated cytotoxicity. J. Immunol. 150, 2091-2101 (1993).
3. 51Cr-labeled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology, 14, 181-196 (1968).
4. COLE, D.J., WILSON, M.C., BARON, P.L., O'BRIEN, P., REED, C., TSANG, K.Y. and SCHLOM, J., Phase I study of recombinant CEA vaccinia virus vaccine with postvaccination CEA peptide challenge. Hum. Gene Ther., 7, 1381-1394 (1996).
5. CORR, M., TIGHE, H., LEE, D., DUDLER, J., TRIEU, M., BRINSON, D.C. and CARSON. D.A., Co-stimulation provided by DNA immunization enhances antitumor immunity. J. Immunol., 159, 4999-5004 (1997).
6. DRAIZE, J.H., Appraisal of the safely of chemicals in foods, drugs, and cosmetics, Association of Food and Drug Officials of the United States, Austin, TX (1965).
7. GLADMAN, D.D., UROWITZ, M.B. and KEYSTONE, E.C., Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features. Amer. J. Med., 2, 210-215 (1979).
8. GUERDER, S., CARDING, S.R. and FLAVELL, R.A., B7 Co-stimulation is necessary for the activation of the lytic function in cytotoxic T lymphocyte precursors. J. Immunol., 155, 5167-5174 (1995).
9. HAYASHI, Y., UTSUYAMA, M., KURASHIMA, C. and HIROKAWA, K., Spontaneous development of organ-specific autoimmune lesions in aged C57BL/6 mice. Clin. exp. Immunol., 78, 120-126 (1989).
10. HELLSTRÖM, K.E., HELLSTRÖM, I., LINSLEY, P. and CHEN, I., On the role of co-stimulation in tumor immunity. Ann. N.Y. Acad. Sci., 690, 225-230 (1993).
11. HODGE, J.W., ABRAMS, S., SCHLOM, J. and KANTOR, J.A., Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 co-stimulatory molecules. Cancer Res., 54, 5552-5555 (1994).
12. HODGE, J.W., MCLAUGHLIN, J.P., ABRAMS, S.I., SHUPERT, W.L., SCHLOM, J. and KANTOR, J.A., Admixture of a recombinant vaccinia virus containing the gene for the co-stimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity. Cancer Res., 55, 3598-3603 (1995a).
13. HODGE, J.W., SCHLOM, J., DONOHUE, S.J., TOMASZEWSKI, J.E., WHEELER, C.W., LEVINE, B.S., GRITZ, L., PANICALI, D. and KANTOR, J.A., A recombinant vaccinia virus expressing human prostate-specific antigen (PSA): safety and Immunogenicity in a non-human primate. Int. J. Cancer, 63, 231-237 (1995b).
14. KALUS, R.M., KANTOR, J.A., GRITZ, L., GOMEZ YAFAL, A., MAZZARA, G.P., SCHLOM, J. and HODGE, J.W., The use of combination vaccinia vaccines and dual-gene vaccinia vaccines to enhance antigen-specific T-cell immunity via T-cell stimulation. Vaccine, 17, 893-903 (1999).
15. KANTOR, J., IRVINE, K., ABRAMS, S., KAUFMAN, H., DIPIETRO, J. and SCHLOM, J., Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine. J. nat. Cancer Inst., 84, 1084-1091 (1992).
16. KATO, K. and HIROKAWA, K., Qualitative and quantitative analysis of autoantibody production in aging mice. In: Aging: immunology and infectious disease, pp. 188-190 Mary Ann Liebert, Inc., New York (1988).
17. KAUFMAN, H., SCHLOM, J. and KANTOR, J., A recombinant vaccinia virus expressing carcinoembryonic antigen (CEA). Int. J. Cancer, 48, 900-907 (1991).
18. KLEIN, R. and 13 OTHERS, Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10 years. Liver, 17, 119-128 (1997).
19. LUSTER, M.I., MUNSON, A.E., THOMAS, P.T., HOLSAPPLE, M.P., FENTERS, J.D., WHITE, K.L., LAUER, L.D., GERMOLAC, D.R., ROSENTHAL, G.J. and DEAN, J.H., Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice. Fund. appl. Toxicol., 10, 2-19 (1988).
20. MITCHISON, H.C., BASSENDINE, M.F., HENDRICK, A., BENNETT, M.K., BIRD, G., WATSON, A.J. and JAMES, O.F., Positive antimitochondrial antibody but normal alkaline phosphatase: is the primary biliary cirrhosis? Hepatology, 6, 1279-1284 (1986).
21. SATOH, M., HAMILTON, K.J., AJMANI, A.K., DONG, X., WANG, J., KANWAR, Y.S. and REEVES, W.H., Autoantibodies to ribosomal pathogen with immune-complex glomerulonephritis in SJL mice treated with Pristane. J. Immunol., 157, 3200-3206 (1996).
22. TSANG, K.Y., ZAREMBA, S., NIERODA, C.A., ZHU, M.Z., HAMILTON, J.M. and SCHLOM, J., Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine. J. nat. Cancer Inst., 87, 982-990 (1995).